Literature DB >> 29653994

Ideal cardiovascular health metrics and its association with 20-year cardiovascular morbidity and mortality in a Chinese population.

Long Zhou1, Liancheng Zhao1, Yong Wu2, Yangfeng Wu3, Xiangmin Gao2, Ying Li1, Jinzhuang Mai2, Zhiqiang Nie2, Yanqiu Ou2, Min Guo1, Xiaoqing Liu2.   

Abstract

BACKGROUND: The American Heart Association (AHA) developed a simplified assessment tool based on seven ideal cardiovascular health (CVH) metrics, but the relationship between the AHA defined ideal CVH metrics and cardiovascular risk in Chinese population has not been well estimated.
METHODS: The baseline survey were conducted among 938 Chinese men and women from four urban and rural population samples in China, aged 35-59 years in 1983-1984. The cohort was followed up for multiple cardiovascular endpoints up to 2005. Cox proportional hazard models were used to test the associations accounting for multiple covariates. Outcomes were collected in 1987-2005 and data analysed in 2017.
RESULTS: During a median of 20.3 years follow-up, 68 non-fatal CVD events and 139 deaths (29 CVD deaths) occurred. The multivariable adjusted HRs and 95% CIs for all CVD in the groups with three and 4-7 ideal CVH metrics were 0.59 (95% CI 0.33 to 1.04) and 0.24 (95% CI 0.12 to 0.47), when the group with 0-2 ideal CVH metrics as the reference. Results also showed that participants with 4-7 ideal CVH metrics had a 54% (95% CI 24% to 72%) lower risk of all-cause mortality in comparison with those with 0-2 ideal metrics.
CONCLUSIONS: The number of ideal CVH metrics was inversely associated with the risk of cardiovascular morbidity and mortality in this Chinese general population. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cardiovascular disease; cohort studies; epidemiology of cardiovascular disease

Mesh:

Year:  2018        PMID: 29653994     DOI: 10.1136/jech-2017-210396

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  6 in total

1.  American heart association's cardiovascular health metrics and risk of cardiovascular disease mortality among a middle-aged male Scandinavian population.

Authors:  Nzechukwu M Isiozor; Setor K Kunutsor; Ari Voutilainen; Sudhir Kurl; Jussi Kauhanen; Jari A Laukkanen
Journal:  Ann Med       Date:  2019-07-12       Impact factor: 4.709

2.  Sex disparities in cardiovascular health metrics among rural-dwelling older adults in China: a population-based study.

Authors:  Xiaolei Han; Ziying Jiang; Yuanjing Li; Yongxiang Wang; Yajun Liang; Yi Dong; Shi Tang; Yifeng Du; Chengxuan Qiu
Journal:  BMC Geriatr       Date:  2021-03-04       Impact factor: 3.921

Review 3.  Further understanding of ideal cardiovascular health score metrics and cardiovascular disease.

Authors:  Erin D Michos; Sadiya S Khan
Journal:  Expert Rev Cardiovasc Ther       Date:  2021-06-15

4.  Poor cardiovascular health status among Chinese women.

Authors:  Tian-Wen Han; Yu-Qi Liu; Wei Dong; Xiao-Juan Bai; Yu-Yang Liu; Xi Su; Yu-Ming Li; Ju-Ying Qian; Mei-Xiang Xiang; Lin Cai; Qian Lin; Jing-Bo Hou; Jie Yang; Dan-Dan Li; Huan-Wan Yang; Shan-Shan Zhou; Jing Wang; Feng Tian; Xue-Qiao Zhao; Yun-Dai Chen
Journal:  BMC Cardiovasc Disord       Date:  2020-11-25       Impact factor: 2.298

5.  Association of Night Sleep Duration and Ideal Cardiovascular Health in Rural China: The Henan Rural Cohort Study.

Authors:  Xueyan Wu; Xiaotian Liu; Wei Liao; Ning Kang; Shengxiang Sang; Tanko Abdulai; Zhihan Zhai; Chongjian Wang; Xiaoqiong Wang; Yuqian Li
Journal:  Front Public Health       Date:  2021-01-11

6.  Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose study.

Authors:  Farzad Hadaegh; Somayeh Hosseinpour-Niazi; Niloofar Deravi; Mitra Hasheminia; Nazanin Moslehi; Hossein Toreyhi; Fereidoun Azizi
Journal:  Front Cardiovasc Med       Date:  2022-08-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.